Repurposing with a Difference
- 12 June 2009
- journal article
- policy forum
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 324 (5933), 1394-1395
- https://doi.org/10.1126/science.1169920
Abstract
Consumer activism, genetic information, and social networking technologies are creating many opportunities for drug repurposing.Keywords
This publication has 16 references indexed in Scilit:
- Decision support methods for the detection of adverse events in post-marketing dataDrug Discovery Today, 2009
- Physician's guide to pharmacovigilance: Terminology and causality assessmentEuropean Journal of Internal Medicine, 2009
- Online Health Information Retrieval by Consumers and the Challenge of Personal GenomicsPublished by Elsevier BV ,2009
- Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDAThe AAPS Journal, 2008
- The Tell-Tale Heart: Population-Based Surveillance Reveals an Association of Rofecoxib and Celecoxib with Myocardial InfarctionPLOS ONE, 2007
- Estimating The Cost Of New Drug Development: Is It Really $802 Million?Health Affairs, 2006
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Are the Economics of Pharmaceutical Research and Development Changing?PharmacoEconomics, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- The Medical Dictionary for Regulatory Activities (MedDRA)Drug Safety, 1999